Global Laparoscopic Power Morcellators Market, by Application (Hysterectomy, Myomectomy, and Others), by End User (Hospital and Clinics, and Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 102.1 million in 2021 and is expected to exhibit a CAGR of 5.3% during the forecast period (2021-2028).
Increasing prevalence of interstitial cystitis is expected to impel the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on November 30, 2021, an article published in the journal of clinical medicine states that interstitial cystitis which is a chronic bladder condition that results in recurring discomfort or pain in the bladder or surrounding pelvic region, the prevalence percentages ranges between 2.7% to 6.5% which represents around 3.3 to 7.9 million women 18 years or older in the U.S. Hence, it indicates the increased requirement of operational procedures by using laparoscopic power morcellators to remove or cut tissues responsible for interstitial cystitis.
Increasing skill development programs by the market players is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. For instance, in 2021, Ethicon, the manufacturer of surgical sutures and wound closure, has decided to conduct laparoscopic gynecology program in the year 2022 in partnership with the British Society for Gynecological Endoscopy (BSGE). The aim of this training program is to develop the skills of laparoscopic surgeon by providing knowledge and technical skills to perform the advanced laparoscopic procedures.
Global Laparoscopic Power Morcellators Market - Impact of Coronavirus (COVID – 19) Pandemic
The coronavirus disease (COVID-19) pandemic is expected to hamper growth of the global laparoscopic power morcellators market over the forecast period. COVID-19 is the recent pandemic outbreak which was first reported on December 31, 2019 in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020. According to the World Health Organization (WHO) Weekly epidemiological update on COVID-19, the number of new cases and deaths continued to decrease, with nearly 281 million cases of COVID-19 were reported globally and with just under 5,411,759 deaths till January 2, 2022.
Increasing delays in elective surgeries by hospitals to avoid COVID-19 transmission, is expected to hamper the growth of the global laparoscopic power morcellators market over the forecast period after pandemic. For instance, on April 1, 2020, an article published in National Center for Biotechnology Information (NCBI) stated that hospitals in all the countries reduce elective and non- urgent cases to allow staffing and resources to be deployed for COVID-19 services. Hence, such delays in elective surgeries hampered the market growth.
Browse 38 Market Data Tables and 42 Figures spread through 196 Pages and in-depth TOC on Global Laparoscopic Power Morcellators Market by Application (Hysterectomy, Myomectomy, and Others), by End User (Hospital and Clinics, and Surgical Centers ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
To know the latest trends and insights prevalent in the laparoscopic power morcellators market, click the link below:
https://www.coherentmarketinsights.com/market-insight/laparoscopic-power-morcellators-market-4905
Increasing prevalence of endometrial cancer globally is expected to drive the growth of the global laparoscopic power morcellators market, over the forecast period. For instance, American institute for cancer research states that globally endometrial cancer is the 15th most common cancer and also mentioned about highest rate of endometrial cancer in countries such as Belarus, Samoa, Macedonia, Lithuania and Canada.
Key Takeaways of the Laparoscopic Power Morcellators Market:
- The global laparoscopic power morcellators market is expected to exhibit a CAGR of 5.3% over the forecast period (2021-2028), owing to growth in potential markets, especially in Europe, while North America region accounted for the major market share.
- Market players are involved in increasing awareness about fibroids which is a benign tumor of muscular and fibrous tissues develops on wall of uterus. On July 1, Fibroid Institute Dallas Celebrated Fibroid Awareness Month, to raise the awareness about fibroids symptoms such as back or leg pain, heavy menstrual bleeding, fatigue and weakness.
- Some of the major players operating in the global laparoscopic power morcellators market include LiNA Medical, Blue Endo, Johnson and Johnson, Hangzhou Kangji Medical Instruments, WISAP Medical Technology, Chimco Bio-Medical Engineering Co., Zhejiang Geyi Medical Instrument, Karl Storz GmbH, Medtronic, Richard Wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation